The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.
about
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The collagen receptor uPARAP/E ...... enchymal and leukemic cancers.
@en
type
label
The collagen receptor uPARAP/E ...... enchymal and leukemic cancers.
@en
prefLabel
The collagen receptor uPARAP/E ...... enchymal and leukemic cancers.
@en
P2093
P2860
P50
P356
P1433
P1476
The collagen receptor uPARAP/E ...... senchymal and leukemic cancers
@en
P2093
Christoffer Fagernæs Nielsen
Henrik Gårdsvoll
Henrik Jessen Jürgensen
Ida Katrine Lund
Kamilla Ellermann Jensen
Kristine Rothaus Christensen
Maria Carlsén Melander
Petra Hamerlik
Sander Maarten van Putten
P2860
P304
44605-44624
P356
10.18632/ONCOTARGET.17883
P407
P577
2017-07-01T00:00:00Z